Search results for "Real"

showing 10 items of 4449 documents

Patient reported feasibility and acceptance of Montreal Cognitive Assessment (MoCA) screening pre- and postoperatively in brain tumour patients.

2018

Abstract Background Montreal Cognitive Assessment (MoCA) represents a short screening tool for neuropsychological deficits. The study’s aim was to test feasibility and acceptance of MoCA in patients with brain tumours perioperatively. Methods Patients with supratentorial located brain tumours were assessed preoperatively (t1, day −1) and postoperatively (t2, day 3–5) using EORTC-QLQ-C30 + BN20, Distress Thermometer (DT) and the MoCA test (different versions). Feasibility was evaluated by a feedback form and patients were asked about perceived discomfort, overstraining or complexity of MoCA. Results of MoCA were correlated with clinical factors. Results 63 patients participated, 19 were male…

AdultMalemedicine.medical_specialtyPhysical functionNeuropsychological TestsSensitivity and SpecificityNeurosurgical Procedures03 medical and health sciences0302 clinical medicinePostoperative ComplicationsPhysiology (medical)Internal medicinemedicineDistress ThermometerHumansIn patientAgedbusiness.industryNeuropsychologyMontreal Cognitive AssessmentSupratentorial NeoplasmsGeneral MedicineMiddle AgedDistressNeurology030220 oncology & carcinogenesisFeasibility StudiesSurgeryFemaleNeurology (clinical)NeurosurgeryCompletion timebusinessCognition Disorders030217 neurology & neurosurgeryJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
researchProduct

An observational study to evaluate the long-term outcomes of treatment with etanercept in patients with plaque-type psoriasis

2015

Background There is an unmet need for long-term, real-life data on the effect of a drug-free interval between treatment cycles in patients with plaque psoriasis being treated with etanercept, which is licensed for intermittent and continuous treatment. Objective The aim of this study was to determine the average duration of the drug-free interval between etanercept treatment cycles in patients with plaque psoriasis. Methods This was a non-interventional, open-label, multicentre, prospective study in patients for whom the decision had already been made to initiate treatment with etanercept during routine practice in German centres. Clinical outcomes were documented over 36 months with study …

AdultMalemedicine.medical_specialtyPopulationDermatologyEtanerceptEtanercept030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePsoriasis Area and Severity IndexInternal medicinePsoriasisClinical endpointHumansPsoriasisMedicineAdverse effecteducationBody surface areaeducation.field_of_studybusiness.industryDermatology Life Quality IndexMiddle Agedmedicine.diseaseSurgeryInfectious Diseases030220 oncology & carcinogenesisFemalebusinessImmunosuppressive Agentsmedicine.drugJournal of the European Academy of Dermatology and Venereology
researchProduct

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

2020

Digital

AdultMalemedicine.medical_specialtyRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansHypoglycemic AgentsCognitive DysfunctionRisk factorAgedbusiness.industryHazard ratioMontreal Cognitive AssessmentMiddle Agedmedicine.diseaseImmunoglobulin Fc FragmentsTreatment OutcomeDiabetes Mellitus Type 2Digit symbol substitution testFemaleDulaglutideNeurology (clinical)business030217 neurology & neurosurgerymedicine.drug
researchProduct

Ureteral realignment with combined access as a treatment of complete ureteral transection.

2019

Ureteral realignment using a ureteral stent can be an alternative treatment in cases of complete ureteral transection and may avoid the need for reconstructive surgery. The combined access can help the passage of the guidewire through the injured area and the threading of the urinary system of the patient. We present a case of a 38-year-old man with multiples abdominal surgeries, who underwent a complete ureteral section treated with ureteral realignment with combined access. The subsequent evolution was favourable, with resolution of the ureteral injury at the acute time, and without the presence of long-term obstruction. Although we must accept that the standard treatment of the complete …

AdultMalemedicine.medical_specialtyReconstructive surgeryUrologyUrinary systemmedicine.medical_treatmentAnastomosisUreteral realignmenturologic and male genital diseaseslcsh:RC870-923Ureteral injurymedicineHumansbusiness.industryurogenital systemStandard treatmentTreatment optionsStentlcsh:Diseases of the genitourinary system. UrologyAlternative treatmentfemale genital diseases and pregnancy complicationsSurgeryUreteral traumasurgical procedures operativeUrologic Surgical ProceduresUreterbusinessEndourologyUreteral transectionArchivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
researchProduct

Lichenoid lesions of the upper lip: A retrospective study of 24 cases.

2017

Background Lichenoid lesions of the upper labial mucosa, without other oral or extraoral manifestations seem to be rare. The clinicopathologic features of 24 such cases are presented and the pertinent literature is reviewed. Material and Methods 24 Caucasian patients that clinically presented lichenoid features on the upper labial mucosa, with or without lichenoid lesions on the adjacent gingiva, were included in the study. Clinical features were extracted from the patients’ records, while dental plaque/calculus accumulation and composite resin restorations of the adjacent teeth were recorded. Four cases where an incisional biopsy was performed were further evaluated. Results There were 8 m…

AdultMalemedicine.medical_specialtyResin restorationsReviewDental plaque030207 dermatology & venereal diseases03 medical and health sciencesYoung Adult0302 clinical medicinestomatognathic systemOral and maxillofacial pathologyMedicineHumansLabial MucosaGeneral DentistryLichenoid lesionsAgedRetrospective StudiesAged 80 and overOral Medicine and Pathologybusiness.industryCalculus (dental)Upper lipRetrospective cohort studyLip DiseasesMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatology3. Good healthstomatognathic diseasesOtorhinolaryngology030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessLichen Planus OralMedicina oral, patologia oral y cirugia bucal
researchProduct

Oral verruciform xanthoma : report of 13 new cases and review of the literature

2018

Background Oral verruciform xanthoma (OVX) is a rare lesion. The purpose of the present study is to describe the clinical features of 13 OVXs and review all cases reported in the English literature. Material and Methods Thirteen cases of OVX diagnosed during a 47-year period were retrospectively collected. The patients’ gender and age, as well as the main clinical features of the lesions were retrieved from the biopsy request forms. Pubmed®, Scopus® and Google ScholarTM electronic databases were searched with the key word “verruciform xanthoma”. Only cases of histologically confirmed OVX were included in the study. Results The 13 OVXs represented approximately 0.04% of 35,617 biopsies acces…

AdultMalemedicine.medical_specialtyReviewAsymptomatic030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePathognomonicTongueBiopsyXanthomatosisHumansMedicineGeneral DentistryAgedRetrospective StudiesVerruciform xanthomaOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryNodule (medicine)030206 dentistryMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Dermatology3. Good healthmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleSurgeryHard palatemedicine.symptomDifferential diagnosisMouth Diseasesbusiness
researchProduct

Effects of sex on naevus body distribution and melanoma risk in two melanoma case-control studies at different latitudes

2016

Naevus count is the most predictable phenotypic risk factor for melanoma and is mainly influenced by genetic factors1,2,3. Melanoma disparities according to gender have been reported in many studies in term of body distribution, survival and to a lesser extent incidence1,2. It is well established that women are more likely to get melanoma on the lower limbs, whilst men are more prone to melanoma on the trunk. In this study, we explore the effects of gender on the distribution of naevi on the body in melanoma cases and controls from different latitudes and whether the odds ratios for melanoma associated with naevi at different body sites are affected by gender. Two case control studies are c…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentDermatologyYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineResidence CharacteristicsRisk FactorsmedicineHumansDistribution (pharmacology)Sex DistributionRisk factorYoung adultMelanomaAgedAged 80 and overLegNevus PigmentedSex CharacteristicsAustralasiabusiness.industryMelanomaCase-control studyTorsoOdds ratioMiddle Agedmedicine.diseaseDermatologyTrunkUnited KingdomHead and Neck NeoplasmsCase-Control Studies030220 oncology & carcinogenesisArmFemalebusinessSex characteristicsBritish Journal of Dermatology
researchProduct

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.

2021

Summary Background Before February, 2021, there was no standard treatment regimen for locally advanced basal cell carcinoma after first-line hedgehog inhibitor (HHI) therapy. Cemiplimab, a PD-1 antibody, is approved for treatment of advanced cutaneous squamous cell carcinoma and has shown clinical activity as monotherapy in first-line non-small-cell lung cancer. Here, we present the primary analysis data of cemiplimab in patients with locally advanced basal cell carcinoma after HHI therapy. Methods We did an open-label, multicentre, single-arm, phase 2 trial across 38 outpatient clinics, primarily at academic medical centres, in Canada, Europe, and the USA. Eligible patients (aged ≥18 years…

AdultMalemedicine.medical_specialtySkin NeoplasmsPyridinesProgrammed Cell Death 1 ReceptorVismodegibAntibodies Monoclonal Humanized030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineCarcinomaClinical endpointOutpatient clinicHumansBasal cell carcinomaAnilidesHedgehog ProteinsLung cancerImmune Checkpoint InhibitorsAgedbusiness.industryStandard treatmentMiddle Agedmedicine.diseaseRegimenOncologyCarcinoma Basal CellDrug Resistance Neoplasm030220 oncology & carcinogenesisFemaleNeoplasm Recurrence LocalSettore MED/35 - MALATTIE CUTANEE E VENEREEbusinessmedicine.drugThe Lancet. Oncology
researchProduct

An adaptive display for the treatment of diverse trauma PTSD victims.

2009

El trastorno de estrés postraumático (TEPT) puede desarrollarse después de la exposición a un evento aterrador. Las personas que sufren de trastorno de estrés postraumático presentan hiperactividad y evitación, y experimentan síntomas que provocan angustia y deterioro en áreas de vida significativas. Los programas de comportamiento cognitivo, incluida la terapia de exposición, son actualmente el tratamiento de elección para el TEPT. Aunque estos programas son eficaces, hay margen de mejora; La utilización de la terapia de exposición por los médicos es baja y las tasas de desgaste son altas. La aplicación de nuevas tecnologías, especialmente la realidad virtual (VR), podría ayudar a superar …

AdultMalemedicine.medical_specialtySocial PsychologyAdolescentmedicine.medical_treatmentExposure therapyPilot ProjectsVirtual realityStatistics NonparametricFight-or-flight responseLife Change EventsStress Disorders Post-TraumaticUser-Computer Interfacemental disordersmedicineHumansComputer SimulationPsychiatryApplied PsychologyAgedCommunicationPatient SelectionFlexibility (personality)CognitionGeneral MedicineMiddle AgedComputer Science ApplicationsHuman-Computer InteractionPosttraumatic stressDistressTreatment OutcomePsicologiaFemalePersonalitatPsychologyClinical psychologyCyberpsychology, behavior and social networking
researchProduct

Timing of quality of life improvements in psoriatic patients treated with different systemic therapies

2019

Psoriasis impacts the quality of life (QoL) by disrupting overall health and social life. Thus, the use of a QoL evaluation item is crucial in assessing a therapeutic regimen. Also, faster improvements in QoL lead to better patient compliance, but very few studies compare psoriasis traditional and biologic therapies timing. To evaluate how much different systemic therapies improve disease severity and QoL, a retrospective analysis was performed on 56 patients. Subjects were administered different drugs and their vital statistics, psoriasis area severity index (PASI) and PSOdisk were collected at baseline and after 30 days. We found a moderate correlation between PASI and PSOdisk score with …

AdultMalemedicine.medical_specialtyTime FactorsAdolescentAnti-Inflammatory AgentsDermatologySeverity of Illness IndexSocial lifeYoung Adult030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDisease severityQuality of lifeSurveys and QuestionnairesPsoriasisInternal medicinesystemic therapiesUstekinumabmedicineHumansPsoriasisPatient complianceAgedRetrospective StudiesSkinpsoriasiAged 80 and overTherapeutic regimenbusiness.industryBiologic therapiesAdalimumabGeneral MedicineMiddle Agedmedicine.diseasehumanitiesBiological TherapyTreatment Outcomequality of life030220 oncology & carcinogenesisCyclosporineFemaleUstekinumabDermatologic AgentsbusinessFollow-Up Studiesmedicine.drug
researchProduct